TransCode Therapeutics (RNAZ) Issues Letter to Shareholders

Go back to TransCode Therapeutics (RNAZ) Issues Letter to Shareholders

TransCode Therapeutics Open Letter to Shareholders

November 12, 2024 7:00 AM UTC

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following open letter to shareholders of the Company:

Dear Shareholders,

At our upcoming Special Meeting to be held November 22, shareholders are being asked to authorize our Board of Directors to effect a reverse split  only if the Board determines that doing so is necessary as described below.

Many shareholders rightly ask why this request. Some believe that the potential announcement of... More